Jazz Pharmaceuticals plc (JAZZ)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 03:51PM EDT. Market open.
| Previous Close | 112.01 |
| Open | 112.37 |
| Bid | 109.45 x 300 |
| Ask | 109.73 x 200 |
| Day's Range | 109.29 - 113.06 |
| 52 Week Range | 103.01 - 146.70 |
| Volume | |
| Avg. Volume | 665,052 |
| Market Cap | 6.981B |
| Beta (5Y Monthly) | 0.63 |
| PE Ratio (TTM) | 22.69 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript May 1, 2024 Jazz Pharmaceuticals plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name is Krista, and I will be your conference operator today. […]
- Zacks
Jazz (JAZZ) International Revenue Performance Explored
Review Jazz's (JAZZ) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
- Simply Wall St.
Jazz Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
Jazz Pharmaceuticals ( NASDAQ:JAZZ ) First Quarter 2024 Results Key Financial Results Revenue: US$902.0m (up 1.0% from...
© 2024 Yahoo. All rights reserved.